morroniside and Uveitis

morroniside has been researched along with Uveitis* in 1 studies

Other Studies

1 other study(ies) available for morroniside and Uveitis

ArticleYear
Morroniside Ameliorates Endotoxin-Induced Uveitis by Regulating the M1/M2 Polarization Balance of Macrophages.
    Journal of immunology research, 2023, Volume: 2023

    Inflammation is closely associated with the pathogenesis of various ocular diseases. Uveitis is a condition characterized by the inflammation of the uvea and ocular tissues that causes extreme pain, decreases visual acuity, and may eventually lead to blindness. The pharmacological functions of morroniside, isolated from. An endotoxin-induced uveitis (EIU) mouse model was constructed and treated with morroniside. The inflammatory response was observed using slit lamp microscopy, and histopathological changes were observed by hematoxylin-eosin staining. The cell count in the aqueous humor was measured using a hemocytometer. The concentrations of TNF-. Morroniside effectively ameliorated the inflammatory response in EIU mice. Furthermore, morroniside significantly reduced the concentrations of IL-1. Collectively, these findings suggest that morroniside may protect against LPS-induced inflammation in uveitis by promoting M2 polarization through the inhibition of the JAK/STAT pathway.

    Topics: Animals; Anti-Inflammatory Agents; Ciliary Body; Endotoxins; Inflammation; Interleukin-6; Janus Kinases; Lipopolysaccharides; Macrophages; Mice; Signal Transduction; STAT Transcription Factors; Tumor Necrosis Factor-alpha; Uveitis

2023